Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 149

1.

Oxalate-degrading microorganisms or oxalate-degrading enzymes: which is the future therapy for enzymatic dissolution of calcium-oxalate uroliths in recurrent stone disease?

Peck AB, Canales BK, Nguyen CQ.

Urolithiasis. 2016 Feb;44(1):45-50. doi: 10.1007/s00240-015-0845-6. Epub 2015 Dec 8.

PMID:
26645869
2.

Csf2 and Ptgs2 Epigenetic Dysregulation in Diabetes-prone Bicongenic B6.NODC11bxC1tb Mice.

Garrigan E, Belkin NS, Seydel F, Han Z, Carter J, McDuffie M, Morel L, Peck AB, Clare-Salzler MJ, Atkinson M, Wasserfall C, Davoodi-Semiromi A, Shi JD, Haskell-Luevano C, Yang LJ, Alexander JJ, Cdebaca A, Piliant T, Riggs C, Amick M, Litherland SA.

Genet Epigenet. 2015 Oct 11;7:5-17. doi: 10.4137/GEG.S29696. eCollection 2015.

3.

Involvement of renin-angiotensin-aldosterone system in calcium oxalate crystal induced activation of NADPH oxidase and renal cell injury.

Tsuji H, Wang W, Sunil J, Shimizu N, Yoshimura K, Uemura H, Peck AB, Khan SR.

World J Urol. 2016 Jan;34(1):89-95. doi: 10.1007/s00345-015-1563-y. Epub 2015 May 17.

PMID:
25981400
4.

Activation of the NLRP3 inflammasome in association with calcium oxalate crystal induced reactive oxygen species in kidneys.

Joshi S, Wang W, Peck AB, Khan SR.

J Urol. 2015 May;193(5):1684-91. doi: 10.1016/j.juro.2014.11.093. Epub 2014 Nov 28.

5.

Regulation of macromolecular modulators of urinary stone formation by reactive oxygen species: transcriptional study in an animal model of hyperoxaluria.

Khan SR, Joshi S, Wang W, Peck AB.

Am J Physiol Renal Physiol. 2014 Jun 1;306(11):F1285-95. doi: 10.1152/ajprenal.00057.2014. Epub 2014 Mar 5.

6.
7.
8.

NADPH oxidase as a therapeutic target for oxalate induced injury in kidneys.

Joshi S, Peck AB, Khan SR.

Oxid Med Cell Longev. 2013;2013:462361. doi: 10.1155/2013/462361. Epub 2013 Jun 6. Review.

9.

The important role of T cells and receptor expression in Sjögren's syndrome.

Karabiyik A, Peck AB, Nguyen CQ.

Scand J Immunol. 2013 Aug;78(2):157-66. doi: 10.1111/sji.12079. Review.

10.

Type I interferon receptor deficiency prevents murine Sjogren's syndrome.

Szczerba BM, Rybakowska PD, Dey P, Payerhin KM, Peck AB, Bagavant H, Deshmukh US.

J Dent Res. 2013 May;92(5):444-9. doi: 10.1177/0022034513483315. Epub 2013 Mar 26.

11.

Systems analysis of primary Sjögren's syndrome pathogenesis in salivary glands identifies shared pathways in human and a mouse model.

Horvath S, Nazmul-Hossain AN, Pollard RP, Kroese FG, Vissink A, Kallenberg CG, Spijkervet FK, Bootsma H, Michie SA, Gorr SU, Peck AB, Cai C, Zhou H, Wong DT.

Arthritis Res Ther. 2012 Nov 1;14(6):R238. doi: 10.1186/ar4081.

12.

Apocynin-treatment reverses hyperoxaluria induced changes in NADPH oxidase system expression in rat kidneys: a transcriptional study.

Joshi S, Saylor BT, Wang W, Peck AB, Khan SR.

PLoS One. 2012;7(10):e47738. doi: 10.1371/journal.pone.0047738. Epub 2012 Oct 16.

13.

Rapid oxalate determination in blood and synthetic urine using a newly developed oxometer.

Canales BK, Richards NG, Peck AB.

J Endourol. 2013 Feb;27(2):145-8. doi: 10.1089/end.2012.0438. Epub 2012 Dec 31.

PMID:
22973856
14.

Gene therapy using IL-27 ameliorates Sjögren's syndrome-like autoimmune exocrinopathy.

Lee BH, Carcamo WC, Chiorini JA, Peck AB, Nguyen CQ.

Arthritis Res Ther. 2012 Jul 24;14(4):R172. doi: 10.1186/ar3925.

15.

Transcriptome analysis of the interferon-signature defining the autoimmune process of Sjögren's syndrome.

Peck AB, Nguyen CQ.

Scand J Immunol. 2012 Sep;76(3):237-45. doi: 10.1111/j.1365-3083.2012.02749.x.

16.

Local delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome.

Yin H, Nguyen CQ, Samuni Y, Uede T, Peck AB, Chiorini JA.

Arthritis Res Ther. 2012 Feb 27;14(1):R40. doi: 10.1186/ar3753.

17.

B-cell tolerance defects in the B6.Aec1/2 mouse model of Sjögren's syndrome.

Meng W, Li Y, Xue E, Satoh M, Peck AB, Cohen PL, Eisenberg RA, Luning Prak ET.

J Clin Immunol. 2012 Jun;32(3):551-64. doi: 10.1007/s10875-012-9663-6. Epub 2012 Feb 17.

18.

The current concept of T (h) 17 cells and their expanding role in systemic lupus erythematosus.

Perry D, Peck AB, Carcamo WC, Morel L, Nguyen CQ.

Arthritis. 2011;2011:810649. doi: 10.1155/2011/810649. Epub 2011 Mar 22.

19.

Enzymatic dissolution of calcium and struvite crystals: in vitro evaluation of biochemical requirements.

Thalji NK, Richards NG, Peck AB, Canales BK.

Urology. 2011 Sep;78(3):721.e13-721.e17. doi: 10.1016/j.urology.2011.04.046. Epub 2011 Jul 13.

20.

Sjögren's syndrome: studying the disease in mice.

Delaleu N, Nguyen CQ, Peck AB, Jonsson R.

Arthritis Res Ther. 2011 Jun 13;13(3):217. doi: 10.1186/ar3313. Review.

Items per page

Supplemental Content

Write to the Help Desk